Searched for
BIOASIA 2025
India committed to collaborating with global stakeholders to address healthcare challenges: Piyush GoyalIndia aims to collaborate internationally on healthcare challenges, offering unique talent and innovation. Union Commerce Minister Piyush G...- India on the verge of becoming clinical trials hub, Parexel executive saysIndia is poised to become a prominent site for early-stage clinical trials, particularly amid the disruptions caused by the Russia-Ukraine ...
- Amgen to invest $200 million in India site, CEO saysAmgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre,...
- Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its dru...
- Biologics worth $50 bn to lose patent protection in USA:Report"It is estimated that between 2009 and 2019, 21 biologics with a market value of over $ 50 billion will lose patent protection in the US al...
- Biosimilars to replace 70% of chemical drugs in 2 decadesBiosimilars products are set to replace some 70% of global chemical drugs over the next couple of decades on account of safety parameters.
Load More